Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1657–1680 of 11,584 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: CHRONIC DISEASE Clear all

Conditions: Heart Failure, Pulmonary Disease, Chronic Obstructive, Emphysema, Pulmonary Fibrosis, Interstitial Lung Disease
Interventions: ADAPT Intervention; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 99 Years
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 2
States / cities: Aurora, Colorado • Seattle, Washington

Conditions: Prostatic Neoplasms
Interventions: Registry; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Alpha-1 Antitrypsin Deficiency
Interventions: No Intervention; Genetic
Lead sponsor: Adverum Biotechnologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: Gainesville, Florida • Charleston, South Carolina

Conditions: Diabetic Kidney Disease, Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2, Chronic Kidney Disease, Stage 3 (Moderate)
Interventions: KidneyIntelX; Diagnostic Test
Lead sponsor: Renalytix AI, Inc.; Industry
Eligibility: 23 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Appendix Carcinoma, Carcinomatosis, Colorectal Carcinoma, Gastric Carcinoma, Malignant Peritoneal Neoplasm, Malignant Solid Neoplasm
Interventions: Biospecimen Collection, Pain Assessment, Questionnaire Administration; Procedure · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Arthritis, Rheumatoid, Pain
Interventions: No intervention; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 5
States / cities: Denver, Colorado • Chicago, Illinois • Baltimore, Maryland + 2 more

Conditions: Neuralgia, Spinal Cord Injuries
Interventions: placebo, pregabalin; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 22
States / cities: Phoenix, Arizona • Fresno, California • Napa, California + 15 more

Conditions: Heart Diseases
Interventions: Smartwatch; Other
Lead sponsor: Tulane University; Other
Eligibility: 18 Years to 120 Years
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: New Orleans, Louisiana

Conditions: Chronic Myelogenous Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Severe Aplastic Anemia
Interventions: umbilical cord blood (UCB); Genetic
Lead sponsor: West Virginia University; Other
Eligibility: 16 Years to 70 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2021
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: B Cells-Tumors, B Cell Chronic Lymphocytic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Large B-Cell Diffuse Lymphoma of Bone (Diagnosis)
Interventions: Idelalisib 100 MG, Placebo Oral Tablet; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetes, Heart Disease, Hypertension, Dyslipidemia
Interventions: CREATE Wellness, Usual Care Control; Behavioral · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 40 Years to 85 Years
Enrollment: 647 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: San Jose, California

Conditions: Chronic Myeloid Leukemia
Interventions: Omacetaxine mepesuccinate; Drug
Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 10
States / cities: Los Angeles, California • Jacksonville, Florida • Atlanta, Georgia + 7 more

Conditions: Cerebral Palsy Spastic Diplegia
Interventions: Short Burst Interval Locomotor Treadmill Training (SBLTT); Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 5 Years to 12 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
Interventions: busulfan, cyclophosphamide, methylprednisolone, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation; Drug · Procedure
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 19 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2001
U.S. locations: 2
States / cities: Baltimore, Maryland • Columbia, South Carolina

Conditions: Chronic Hepatitis C
Interventions: PPI-668, BI 207127 Dose 1, BI 207127 Dose 2, Faldaprevir, Ribavirin, BI 207127 Placebo; Drug
Lead sponsor: Presidio Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Foot Ulcer, Diabetic
Interventions: Medical Food, Drink mix calorically similar to experimental product; Other
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 18 Years and older
Enrollment: 271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 46
States / cities: Birmingham, Alabama • Tucson, Arizona • Brawley, California + 38 more

Conditions: Chronic Low Back Pain
Interventions: gabapentin, Inert placebo; Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years to 70 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: San Diego, California

Conditions: Covid19, Post-acute COVID-19 Respiratory Disease
Interventions: LYT-100, Placebo; Drug · Other
Lead sponsor: PureTech; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 15
States / cities: Birmingham, Alabama • Florence, Alabama • Los Angeles, California + 12 more

Conditions: Cerebral Palsy, Prematurity
Interventions: Not listed
Lead sponsor: Charles R. Neal,; Other
Eligibility: Up to 2 Months
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Cervical Spinal Cord Plasticity
Interventions: SCAP, MagPro X100, Digitimer DS8R, Paired non-associative stimulation; Other · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Hepatic Encephalopathy, HE, Cirrhosis, Altered Mental Status, AMS
Interventions: Lactulose, Polyethylene Glycol 3350; Drug
Lead sponsor: New York Presbyterian Brooklyn Methodist Hospital; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Chronic Fatigue Syndrome
Interventions: Poly I: Poly C12U (Rintatolimod); Drug
Lead sponsor: AIM ImmunoTech Inc.; Industry
Eligibility: 18 Years to 70 Years
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 2
States / cities: Incline Village, Nevada • Charlotte, North Carolina

Conditions: Thrombocytopenia, Hepatitis C
Interventions: Eltrombopag; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Asthma, COPD (Chronic Obstructive Pulmonary Disease)
Interventions: GB-0895 (SC), Placebo (SC); Biological · Drug
Lead sponsor: Generate Biomedicines; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 6
States / cities: DeLand, Florida • Miami, Florida • Orlando, Florida + 3 more

Search by objective public record fields.

Advancing Symptom Alleviation With Palliative Treatment

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

Long-Term Follow-up Study of ADVM-043

Prospective Decision Impact Trial of KidneyIntelX

Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy

Chronic Pain in Rheumatoid Arthritis

A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury

Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology

Unrelated Umbilical Cord Blood (UBC)Transplantation

Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies

The CREATE Wellness Study

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Cerebral Palsy: Short-burst Interval Training

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C

Evaluation of a Medical Food for Chronic Wounds

Chronic Low Back Pain Research Project

LYT-100 in Post-acute COVID-19 Respiratory Disease

Study of Generalized Movements for Early Prediction of Cerebral Palsy

Cervical Spinal Cord Associative Plasticity

Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)

Ampligen in Chronic Fatigue Syndrome

Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C

A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD